Table 8.

Recommended Surveillance for Individuals with FARS2 Deficiency: Later-Onset Spastic Paraplegia

System/ConcernEvaluationFrequency
Musculoskeletal PT/OT eval; assessment for contractures, scoliosis, & foot deformities; consider need for positioning &/or mobility devices.Each visit
Neurologic Monitor those w/seizures as clinically indicated.If concerns for new seizure activity or progression of seizures; seizures are usually brief & resolve over time
Assess for new manifestations such as myoclonus, tremor, bradykinesia, dystonia, dysarthria.Each visit
Development Monitor developmental progress & educational needs.If concern for developmental delay / learning difficulties

OT = occupational therapy; PT = physical therapy

From: FARS2 Deficiency

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.